Neuropsychiatric reactions with the use of montelukast
- PMID: 35351683
- DOI: 10.1136/bmj-2021-067554
Neuropsychiatric reactions with the use of montelukast
Conflict of interest statement
Competing interests: We have read and understood the BMJ Group policy on declaration of interests and declare the following interests: VS is an administrator of the Montelukast Singulair Side Effects Support and Discussion Group.
Comment in
-
Recognising and reporting paediatric side effects.BMJ. 2022 Jun 29;377:o1559. doi: 10.1136/bmj.o1559. BMJ. 2022. PMID: 35768076 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources